ClinConnect ClinConnect Logo
Search / Trial NCT06707623

CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing

Launched by EVANGELISMOS HOSPITAL · Nov 25, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Dysfunctional Breathing Pulmonary Rehabilitation Breathing Retraining

ClinConnect Summary

This clinical trial is exploring a new approach to help patients with dysfunctional breathing (DB), a condition that affects how people breathe but isn't caused by other serious lung diseases. Researchers want to find out if a special rehabilitation program, guided by exercise tests, is more effective than standard physiotherapy, which is the usual treatment. The study is currently recruiting adults aged 18 and older who have been diagnosed with DB and can commit to an 8-week rehabilitation program that includes attending 5 physiotherapy sessions over 9 weeks.

To participate, individuals must be able to attend outpatient sessions and willing to sign a consent form. However, those with certain conditions like chronic obstructive pulmonary disease (COPD), uncontrolled asthma, or serious health issues that limit their ability to participate will not be eligible. Participants can expect to engage in a structured program designed specifically for their breathing issues, with the goal of improving their overall respiratory health and quality of life. This trial aims to provide valuable insights into the best ways to support patients with dysfunctional breathing.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Dysfunctional breathing (DB) diagnosed with CPET.
  • Adult patients (\>18 years of age)
  • Able and willing to attend an outpatient multidisciplinary, supervised rehabilitation program of a total duration of two months (8 weeks).
  • Able and willing to attend 5 physiotherapy sessions over a period of 9 weeks.
  • Sign an informed consent.
  • Exclusion Criteria:
  • No underling pathology explaining dyspnea and DB in CPET (e.g normal dead space to tidal volume ratio (VD/Vt) and normal alveolar-arterial (A-a) gradient.)
  • Patients with COPD
  • Patients with uncontrolled asthma
  • Patients with post-exertional malaise (PEM).
  • Patients that cannot attend an outpatient rehabilitation program like suffering from dementia, chronically paralyzed, with paraplegia, multiple injuries, or other serious orthopaedic problems that cause disability or suffer from very serious underlying diseases such as end-stage cancer, and patients with neurological diseases that cause disability, require specialized rehabilitation clinics and special interventions (speech therapy, kinesiotherapy, etc.).

About Evangelismos Hospital

Evangelismos Hospital is a leading healthcare institution dedicated to advancing medical research and clinical trials. With a commitment to excellence in patient care and innovative therapies, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experienced professionals to conduct rigorous clinical studies. Evangelismos Hospital aims to contribute to the scientific community by facilitating the development of new treatments and improving health outcomes, while prioritizing patient safety and ethical standards throughout the research process.

Locations

Athens, Attica, Greece

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported